Serum and Bronchoalveolar Lavage Fluid Levels of Cytokines in Patients with Lung Cancer and Chronic Lung Disease: A Prospective Comparative Study.
bronchial lavage
cytokines
interleukins
lung cancer
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
14 Jun 2023
14 Jun 2023
Historique:
received:
09
05
2023
revised:
06
06
2023
accepted:
13
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
The role of chronic inflammation in the initiation and progression of carcinogenesis has been well-established in previous studies, particularly in the stages of malignant conversion, invasion, and metastasis. This study aimed to explore the potential correlation between the levels of cytokines in serum and bronchoalveolar lavage fluid (BALF) by comparing their levels between patients with lung cancer and those with benign lung diseases. The study measured the concentration of IFN-γ, TNF-α, IL-1β, IL-2, IL-4, IL-6, IL-10, and IL-12p70, in venous blood and BALF of a total of 33 patients with lung cancer and 33 patients with benign lung diseases. Significant differences were found between the two groups in various clinical parameters. The cytokine levels were significantly higher among patients with malignant disease, while the BALF analysis revealed higher cytokine levels compared with serum analysis. It was discovered that the levels of cancer-specific cytokines in the lavage fluid increased significantly sooner and were present at a greater concentration than those in the peripheral blood. After one month of treatment, the serum markers decreased significantly but slower in the lavage fluid. The differences between serum and BALF markers remained significant. It was observed that the highest correlation was among IL-6 (serum) and IL-6 (lavage), with a coefficient of 0.774 (
Identifiants
pubmed: 37373987
pii: jpm13060998
doi: 10.3390/jpm13060998
pmc: PMC10303634
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Scand J Immunol. 2003 Feb;57(2):173-8
pubmed: 12588664
Int J Cancer. 2013 May 1;132(9):1977-85
pubmed: 23034889
Cureus. 2020 Oct 24;12(10):e11122
pubmed: 33133790
Asian Pac J Cancer Prev. 2013;14(4):2443-6
pubmed: 23725155
Oncologist. 2006 Apr;11(4):397-408
pubmed: 16614236
Biosci Rep. 2012 Feb;32(1):1-15
pubmed: 21981137
Sci Rep. 2014 Jul 07;4:5595
pubmed: 24999009
Arch Immunol Ther Exp (Warsz). 2006 Mar-Apr;54(2):143-7
pubmed: 16648974
Oncology. 2006;70(2):115-25
pubmed: 16645324
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Lung India. 2019 Jul;36(Supplement):S37-S89
pubmed: 32445309
J Clin Invest. 2007 May;117(5):1175-83
pubmed: 17476347
J Geriatr Oncol. 2019 Mar;10(2):265-271
pubmed: 30078713
Chin Med J (Engl). 2013 Oct;126(20):3931-5
pubmed: 24157160
Neoplasma. 1996;43(3):155-8
pubmed: 8841501
Eur J Cancer. 2013 May;49(7):1725-40
pubmed: 23298711
Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):357-68
pubmed: 12220549
J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22
pubmed: 21685357
Evid Based Complement Alternat Med. 2022 Aug 9;2022:4641600
pubmed: 35982995
JTO Clin Res Rep. 2020 Feb 11;1(1):100001
pubmed: 34589908
Clin Chest Med. 2020 Mar;41(1):1-24
pubmed: 32008623
Respiration. 2005 May-Jun;72(3):285-95
pubmed: 15942298
Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):488-97
pubmed: 26711330
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
Med Oncol. 2005;22(4):353-8
pubmed: 16260852
Lung Cancer. 2009 May;64(2):219-25
pubmed: 18845357
Cancer Immunol Immunother. 2021 Jul;70(7):1867-1876
pubmed: 33394095
Cytokine. 2010 Apr;50(1):30-6
pubmed: 20044268
Adv Exp Med Biol. 2014;816:1-23
pubmed: 24818717
Sci Rep. 2013 Dec 11;3:3473
pubmed: 24326979
Biomark Cancer. 2015 Jul 08;7:25-9
pubmed: 26244033
Afr Health Sci. 2019 Jun;19(2):2147-2155
pubmed: 31656499
Front Immunol. 2020 Sep 02;11:1859
pubmed: 32983102
Endosc Ultrasound. 2014 Oct;3(4):205-12
pubmed: 25485267
J Natl Compr Canc Netw. 2012 Feb;10(2):240-65
pubmed: 22308518
Cochrane Database Syst Rev. 2013 Jun 21;(6):CD001991
pubmed: 23794187
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Oncotarget. 2017 Jun 20;8(25):40946-40957
pubmed: 28402963
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Clin Lung Cancer. 2003 Jul;5(1):46-62
pubmed: 14596704
J Am Heart Assoc. 2019 Dec 3;8(23):e014240
pubmed: 31771438
Expert Rev Proteomics. 2021 Jan;18(1):49-64
pubmed: 33612047
BMC Med Inform Decis Mak. 2013 Jul 19;13:72
pubmed: 23870327